Trending...
- Badanamu and Friends Live Brings Hit Animated Series to Stages Across the United States
- Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not
- As Canada and America Turn on Each Other, These Two Authors Stay On Speaking Terms
UTRECHT, Netherlands, May 30, 2024 ~ FutureBridge, a leading techno-commercial consulting and advisory company, is gearing up to engage with industry leaders at two highly anticipated conferences. The company's life sciences practice, which provides strategic guidance to global companies in the pharmaceutical, biotech, medtech, diagnostics, and animal health sectors, will be participating in the 2024 ASCO (American Society of Clinical Oncology) Annual Meeting and the BIO International Conference 2024.
According to Shivali Jasrotia, Senior Consultant at FutureBridge, the company is excited to share their expertise on the future of medicines, healthcare solutions, disruptive trends, emerging technologies, and therapeutic platforms at these conferences. They also aim to strengthen relationships with existing clients and establish new collaborations with industry experts from academia, patient advocacy groups, innovators, and key opinion leaders.
The ASCO 2024 Annual Meeting will take place in Chicago from May 31st to June 4th and is expected to attract over 40,000 members. This conference will showcase breakthroughs in oncology including advancements in immune checkpoint blockade optimization, lung cancer treatment, breast cancer diagnostics, early melanoma intervention, and early-stage rectal cancer management. Major pharmaceutical companies will also present outcomes and updates of their clinical programs.
More on illi News
"We will be closely following key clinical trial abstracts presented by companies like AstraZeneca,Janssen,and Bristol Myers Squibb at ASCO 2024. Our team is passionate about these topics and we will be providing a short but insightful analysis for our industry colleagues who are unable to attend this event. We are happy to share this analysis with anyone who requests it," said Jasrotia.
The BIO International Conference 2024 will take place in San Diego from June 3rd to June 6th and is considered the premier biotech networking event with over 20,000 industry leaders expected to attend. This year's participants include top biopharmaceutical companies such as Amgen, Pfizer, Novartis, Merck, and Gilead Sciences. The conference aims to facilitate the discovery of new opportunities and the development of partnerships within the biotech and pharmaceutical sectors.
FutureBridge believes that their expertise in tracking early signals in the industry and their implications sets them apart. They offer solutions for the volatile, uncertain, complex, and ambiguous (VUCA) world through their advisory and consulting services. "We believe that business uncertainties from rising failure risks, declining R&D productivity, high unmet clinical needs, and margin pressures can be overcome with a culture of collective and open innovation. Conferences like ASCO, ESMO, and BIO International bridge gaps in scientific data, uniting the competition, world, and technology for a better future," said Manoj Jiandani, Practice Area Head at FutureBridge.
More on illi News
Jiandani also encourages industry leaders to meet with FutureBridge at ASCO 2024 or BIO International this year to learn how their evidence-based consulting solutions can drive results for pharma leaders and address their most critical business challenges. Interested parties can schedule a meeting or reach out to FutureBridge via email at for more information.
In conclusion, FutureBridge's participation in these conferences highlights their commitment to staying at the forefront of industry developments and providing valuable insights to their clients. With a focus on innovation and collaboration, they aim to help businesses navigate the ever-changing landscape of the life sciences industry.
According to Shivali Jasrotia, Senior Consultant at FutureBridge, the company is excited to share their expertise on the future of medicines, healthcare solutions, disruptive trends, emerging technologies, and therapeutic platforms at these conferences. They also aim to strengthen relationships with existing clients and establish new collaborations with industry experts from academia, patient advocacy groups, innovators, and key opinion leaders.
The ASCO 2024 Annual Meeting will take place in Chicago from May 31st to June 4th and is expected to attract over 40,000 members. This conference will showcase breakthroughs in oncology including advancements in immune checkpoint blockade optimization, lung cancer treatment, breast cancer diagnostics, early melanoma intervention, and early-stage rectal cancer management. Major pharmaceutical companies will also present outcomes and updates of their clinical programs.
More on illi News
- Merlin's Pet Therapy Wrap Introduces a Versatile Approach to Hot and Cold Therapy for Dogs
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Patented NogginLOC Technology Offers an Innovative Approach to Helmet Fastening
- Mandeville Pests May Pose Serious Health Risks for Your Family
- City of Chicago Partners With Chicago River Swim to Re-Launch "The Big Jump," Expand Field to 750 Swimmers
"We will be closely following key clinical trial abstracts presented by companies like AstraZeneca,Janssen,and Bristol Myers Squibb at ASCO 2024. Our team is passionate about these topics and we will be providing a short but insightful analysis for our industry colleagues who are unable to attend this event. We are happy to share this analysis with anyone who requests it," said Jasrotia.
The BIO International Conference 2024 will take place in San Diego from June 3rd to June 6th and is considered the premier biotech networking event with over 20,000 industry leaders expected to attend. This year's participants include top biopharmaceutical companies such as Amgen, Pfizer, Novartis, Merck, and Gilead Sciences. The conference aims to facilitate the discovery of new opportunities and the development of partnerships within the biotech and pharmaceutical sectors.
FutureBridge believes that their expertise in tracking early signals in the industry and their implications sets them apart. They offer solutions for the volatile, uncertain, complex, and ambiguous (VUCA) world through their advisory and consulting services. "We believe that business uncertainties from rising failure risks, declining R&D productivity, high unmet clinical needs, and margin pressures can be overcome with a culture of collective and open innovation. Conferences like ASCO, ESMO, and BIO International bridge gaps in scientific data, uniting the competition, world, and technology for a better future," said Manoj Jiandani, Practice Area Head at FutureBridge.
More on illi News
- Mayor Brandon Johnson and Chicago Public Schools Extend Chicago Connected Program for 2026–27 School Year
- Hardwood Flooring vs Carpet Comparison: Premier Custom Hardwood Flooring Releases Ultimate Buyer's Guide
- The Kryder Law Group, LLC Recovers $1,350,000 in Two Motorcycle Accident Settlements
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
Jiandani also encourages industry leaders to meet with FutureBridge at ASCO 2024 or BIO International this year to learn how their evidence-based consulting solutions can drive results for pharma leaders and address their most critical business challenges. Interested parties can schedule a meeting or reach out to FutureBridge via email at for more information.
In conclusion, FutureBridge's participation in these conferences highlights their commitment to staying at the forefront of industry developments and providing valuable insights to their clients. With a focus on innovation and collaboration, they aim to help businesses navigate the ever-changing landscape of the life sciences industry.
Filed Under: Business
0 Comments
Latest on illi News
- Digi 995: Kart Race Expands With New Tracks, Power-Ups, Cup Races and Two New Expansions
- Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
- Tales of Wonder and Dread Celebrates Anniversary with a Classic
- Paul Ohana - From Beverly Hills Salon Chair To Beauty Founder Celebrity Hair Expert
- ChargeOn Announces Conversational Payment Management Solution
- King Larry Steps Into His Moment With Music, Major Performances and a Story Built on Persistence
- Naperville: Sept. 11 Remembrance Ceremony at Cmdr. Dan Shanower Memorial
- Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center
- Redefining Proactive Care: The Rise of the Hybrid Concierge Medical Model
- As Canada and America Turn on Each Other, These Two Authors Stay On Speaking Terms
- GitKraken Names Jim Shaw CEO as Software Teams Move From AI Adoption to Multi-Agent Orchestration
- Brévant Guide Launches New National Restaurant Guide Across Canada
- Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not
- Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing
- Christina McQueen Launches Kickstarter for "One Plate, One Person"
- New Large-Print Medical Organizer Helps Seniors Keep Health Information in One Place
- Chinese Furniture Manufacturers Selling Directly to U.S. Consumers
- Art Takes Over Main Street at the 49th Annual Downers Grove Fine Arts Festival, Sept. 12-13, 2026
- VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING